Cite
MLA Citation
M. Matasar et al.. “P1126: MOSUNETUZUMAB IS EFFICACIOUS AND WELL TOLERATED IN PATIENTS AGED <65 AND ≥65 YEARS WITH RELAPSED/REFRACTORY FOLLICULAR LYMPHOMA AND ≥2 PRIOR THERAPIES: SUBGROUP ANALYSIS OF A PIVOTAL PHASE II STUDY.” HemaSphere, vol. 6, n.d., pp. 1016–1017. http://access.bl.uk/ark:/81055/vdc_100159756296.0x000010